Vinexin {beta} Ablation Inhibits Atherosclerosis in Apolipoprotein E-Deficient Mice by Inactivating the Akt-Nuclear Factor {kappa}B Inflammatory Axis [Valvular Heart Disease]

ConclusionsVinexin β deficiency attenuates atherogenesis primarily by suppressing vascular inflammation and inactivating Akt–nuclear factor κB signaling. Our data suggest that vinexin β could be a therapeutic target for the treatment of atherosclerosis.

Source: JAHA:Journal of the American Heart Association - February 16, 2017 Category: Cardiology Authors: Guan, H., Cheng, W.-L., Guo, J., Chao, M.-L., Zhang, Y., Gong, J., Zhu, X.-Y., She, Z.-G., Huang, Z., Li, H. Tags: Atherosclerosis, Vascular Disease Original Research Source Type: research